Skip to main content
Top
Published in: Cancer Causes & Control 7/2016

01-07-2016 | Brief report

Associations of an abnormal Pap test result with attitudes and beliefs relevant to cervical cancer: a study of rural Appalachian women

Authors: Richard A. Crosby, Robin Vanderpool, Cissi Jones

Published in: Cancer Causes & Control | Issue 7/2016

Login to get access

Abstract

Purpose

To compare women who recall being informed of an abnormal Pap to those not having this experience relative to attitudes and beliefs pertaining to screening for cervical cancer.

Methods

Four hundred women were recruited from eight rural Appalachian counties, in 2013 and 2014. Women completed a paper-and-pencil survey after providing written informed consent. Bivariate associations and age-adjusted associations were calculated between the self-reported experience of being told of an abnormal Pap test result and eight attitudes/beliefs relative to the prevention of cervical cancer. Data analyses were performed in 2014.

Results

The mean age was 40.2 years (range 30–64 years). Eighteen women chose not to answer the question asking about ever having an abnormal Pap test result, leaving n = 382. Of the 382 women who did answer, 122 (30.6 %) indicated having an abnormal Pap test result and the remaining 260 (65.2 %) indicated never having this experience. With the exception of one item assessing knowledge that HPV is the cause of cervical cancer, between-group differences in attitudes, beliefs, and intent to have a Pap test the next time one is due were not observed.

Conclusions

Although we hypothesized that women ever having an abnormal Pap test may have actively sought to learn more about cervical cancer and its prevention, findings suggest that this is not the case. Informing women of an abnormal result could be coupled with a high-intensity counseling designed to improve attitudes and beliefs relative to women’s role in protecting themselves from cervical cancer.
Literature
3.
go back to reference Folkman S, Moskowitz J (2000) Positive affect and the other side of coping. Am Psychol 55:647–654CrossRefPubMed Folkman S, Moskowitz J (2000) Positive affect and the other side of coping. Am Psychol 55:647–654CrossRefPubMed
4.
go back to reference Centers for Disease Control and Prevention (2010) Sexually transmitted diseases treatment guidelines, 2010. MMWR 59:75–79 Centers for Disease Control and Prevention (2010) Sexually transmitted diseases treatment guidelines, 2010. MMWR 59:75–79
5.
go back to reference Bertram CC, Magnussen L (2008) Informational needs and the experiences of women with abnormal Papanicolaou smears. J Am Acad Nurse Pract 20:455–462CrossRefPubMed Bertram CC, Magnussen L (2008) Informational needs and the experiences of women with abnormal Papanicolaou smears. J Am Acad Nurse Pract 20:455–462CrossRefPubMed
6.
go back to reference Eggleston KS, Coker AL, Prabhu I, Cordray ST, Luchok KJ (2007) Understanding barriers for adherence to follow-up care for abnormal Pap tests. J Women’s Health 16:312–330CrossRef Eggleston KS, Coker AL, Prabhu I, Cordray ST, Luchok KJ (2007) Understanding barriers for adherence to follow-up care for abnormal Pap tests. J Women’s Health 16:312–330CrossRef
Metadata
Title
Associations of an abnormal Pap test result with attitudes and beliefs relevant to cervical cancer: a study of rural Appalachian women
Authors
Richard A. Crosby
Robin Vanderpool
Cissi Jones
Publication date
01-07-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 7/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0765-y

Other articles of this Issue 7/2016

Cancer Causes & Control 7/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine